1
|
Delsoglio M, Griffen C, Syed R, Cookson T, Saliba H, Vowles A, Davies S, Willey N, Thomas J, Millen N, Odeh N, Longstaff J, Westran N, Allan L, Offer H, Howell C, Sanders M, Gaffigan K, Garrett K, Foster S, Salt A, Carter E, Moore S, Bergin N, Roper J, Alvarez J, Voss C, Connolly T, MacDonald C, Thrower T, Sills D, Baxter J, Manning R, Gray L, Voas K, Richardson S, Hurren AM, Murphy D, Blake S, McArdle P, Walsh S, Booth L, Albrich L, Ashley-Maguire S, Allison J, Brook S, Capener R, Hubbard GP, Stratton RJ. A multi-center prospective study of plant-based nutritional support in adult community-based patients at risk of disease-related malnutrition. Front Nutr 2023; 10:1297624. [PMID: 38024371 PMCID: PMC10667471 DOI: 10.3389/fnut.2023.1297624] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2023] [Accepted: 10/19/2023] [Indexed: 12/01/2023] Open
Abstract
Introduction There is an emerging need for plant-based, vegan options for patients requiring nutritional support. Methods Twenty-four adults at risk of malnutrition (age: 59 years (SD 18); Sex: 18 female, 6 male; BMI: 19.0 kg/m2 (SD 3.3); multiple diagnoses) requiring plant-based nutritional support participated in a multi-center, prospective study of a (vegan suitable) multi-nutrient, ready-to-drink, oral nutritional supplement (ONS) [1.5 kcal/mL; 300 kcal, 12 g protein/200 mL bottle, mean prescription 275 mL/day (SD 115)] alongside dietary advice for 28 days. Compliance, anthropometry, malnutrition risk, dietary intake, appetite, acceptability, gastrointestinal (GI) tolerance, nutritional goal(s), and safety were assessed. Results Patients required a plant-based ONS due to personal preference/variety (33%), religious/cultural reasons (28%), veganism/reduce animal-derived consumption (17%), environmental/sustainability reasons (17%), and health reasons (5%). Compliance was 94% (SD 16). High risk of malnutrition ('MUST' score ≥ 2) reduced from 20 to 16 patients (p = 0.046). Body weight (+0.6 kg (SD 1.2), p = 0.02), BMI (+0.2 kg/m2 (SD 0.5), p = 0.03), total mean energy (+387 kcal/day (SD 416), p < 0.0001) and protein intake (+14 g/day (SD 39), p = 0.03), and the number of micronutrients meeting the UK reference nutrient intake (RNI) (7 vs. 14, p = 0.008) significantly increased. Appetite (Simplified Nutritional Appetite Questionnaire (SNAQ) score; p = 0.13) was maintained. Most GI symptoms were stable throughout the study (p > 0.06) with no serious adverse events related. Discussion This study highlights that plant-based nutrition support using a vegan-suitable plant-based ONS is highly complied with, improving the nutritional outcomes of patients at risk of malnutrition.
Collapse
Affiliation(s)
- Marta Delsoglio
- Research & Innovation, Nutricia Ltd., Trowbridge, United Kingdom
| | - Corbin Griffen
- Research & Innovation, Nutricia Ltd., Trowbridge, United Kingdom
| | | | | | | | - Amanda Vowles
- Trowbridge Health Centre, Trowbridge, United Kingdom
| | | | | | | | - Nicola Millen
- Cowplain Family Practice, Waterlooville, United Kingdom
| | - Nour Odeh
- Cowplain Family Practice, Waterlooville, United Kingdom
| | | | - Naomi Westran
- Department of Nutrition and Dietetics, Royal Surrey NHS Foundation Trust, Royal Surrey County Hospital, Guildford, United Kingdom
| | - Lindsey Allan
- Department of Nutrition and Dietetics, Royal Surrey NHS Foundation Trust, Royal Surrey County Hospital, Guildford, United Kingdom
| | - Hannah Offer
- Dietetic Department, Thorpe Health Centre, Norfolk Community Health and Care NHS Trust, Norwich, United Kingdom
| | - Chloe Howell
- Dietetic Department, Thorpe Health Centre, Norfolk Community Health and Care NHS Trust, Norwich, United Kingdom
| | - Meg Sanders
- Dietetic Department, Thorpe Health Centre, Norfolk Community Health and Care NHS Trust, Norwich, United Kingdom
| | - Kirsty Gaffigan
- Dietetic Department, Thorpe Health Centre, Norfolk Community Health and Care NHS Trust, Norwich, United Kingdom
| | - Kirby Garrett
- Dietetic Department, Thorpe Health Centre, Norfolk Community Health and Care NHS Trust, Norwich, United Kingdom
| | - Sally Foster
- Nutrition and Dietetic Department, North Tyneside District General Hospital, Tyne and Wear, United Kingdom
| | - Agnes Salt
- Nutrition and Dietetic Department, North Tyneside District General Hospital, Tyne and Wear, United Kingdom
| | - Emily Carter
- Nutrition and Dietetic Department, North Tyneside District General Hospital, Tyne and Wear, United Kingdom
| | - Sarah Moore
- Nutrition and Dietetic Department, North Tyneside District General Hospital, Tyne and Wear, United Kingdom
| | - Nick Bergin
- Department of Nutrition and Dietetics, Airedale General Hospital, Keighley, West Yorkshire, United Kingdom
| | - Jane Roper
- Warden Lodge Medical Practice, Cheshunt, United Kingdom
| | - Joe Alvarez
- Warden Lodge Medical Practice, Cheshunt, United Kingdom
| | | | | | | | | | - Darren Sills
- Nutrition and Dietetics, Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, United Kingdom
| | - Janet Baxter
- Department Nutrition and Dietetics, Kings Cross Hospital, Dundee, United Kingdom
| | - Rhonda Manning
- Department Nutrition and Dietetics, Kings Cross Hospital, Dundee, United Kingdom
| | - Lynsey Gray
- Dietetics, Victoria Integrated Care Centre, Helensburgh, United Kingdom
| | - Karen Voas
- Dietetic Department, Betsi Cadwaladr University Health Board, Denbighshire, United Kingdom
| | - Scot Richardson
- James Alexander Family Practice, Bransholme South Health Centre, Hull, United Kingdom
| | - Anne-Marie Hurren
- James Alexander Family Practice, Bransholme South Health Centre, Hull, United Kingdom
| | | | | | - Paul McArdle
- Birmingham Community Nutrition, Birmingham, United Kingdom
| | - Sinead Walsh
- Birmingham Community Nutrition, Birmingham, United Kingdom
| | - Lucy Booth
- Birmingham Community Nutrition, Birmingham, United Kingdom
| | | | | | | | - Sarah Brook
- Dietetics, Princess Royal Health Centre, Huddersfield, United Kingdom
| | - Rebecca Capener
- Research & Innovation, Nutricia Ltd., Trowbridge, United Kingdom
| | - Gary P. Hubbard
- Research & Innovation, Nutricia Ltd., Trowbridge, United Kingdom
| | - Rebecca J. Stratton
- Research & Innovation, Nutricia Ltd., Trowbridge, United Kingdom
- Faculty of Medicine, University of Southampton, Southampton, United Kingdom
| |
Collapse
|
2
|
Yule A, Sills D, Smith S, Spiller R, Smyth AR. Thinking outside the box: a review of gastrointestinal symptoms and complications in cystic fibrosis. Expert Rev Respir Med 2023; 17:547-561. [PMID: 37345513 DOI: 10.1080/17476348.2023.2228194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2023] [Accepted: 06/19/2023] [Indexed: 06/23/2023]
Abstract
INTRODUCTION Gastrointestinal (GI)-related symptoms, complications, and comorbidities in cystic fibrosis (CF) are common and research to reduce their burden is a priority for the CF community. To enable future research, this review aimed to summarize the range of GI symptoms, complications and comorbidities seen in CF, the underlying pathophysiology, and treatments. AREAS COVERED This was a rapid systematic review undertaken using the recommendations from the Cochrane Rapid Reviews Methods Group. We searched databases including PubMed, Embase, Medline and the Cochrane database and identified those studies reporting GI-related symptoms, complications, or comorbidities in CF or their treatment. Our searches identified 2,930 studies and a total 119 studies met our inclusion criteria. Where a prevalence could be determined, GI symptoms were reported in 33.7% of study participants. The range of symptoms reported was broad and the highest median prevalence included flatulence (43.5%), bloating and abdominal distension (36%), and fatty stool (36%). Meconium ileus was reported in 12% and distal intestinal obstruction syndrome in 8.5. EXPERT OPINION GI-related symptoms, complications, and comorbidities in CF are common. More consistent characterization and recording of these symptoms in clinical studies may help achieve the priority of reducing the burden of GI disease in CF.
Collapse
Affiliation(s)
- Alexander Yule
- Academic Unit of Lifespan & Population Health, School of Medicine, University of Nottingham, Nottingham, UK
- NIHR Biomedical Research Centre, Nottingham University Hospital NHS Trust and University of Nottingham, Nottingham, UK
| | - Darren Sills
- Nutrition and Dietetics, Nottingham University Hospitals NHS Trust, Nottingham, UK
| | - Sherie Smith
- Academic Unit of Lifespan & Population Health, School of Medicine, University of Nottingham, Nottingham, UK
| | - Robin Spiller
- NIHR Biomedical Research Centre, Nottingham University Hospital NHS Trust and University of Nottingham, Nottingham, UK
- Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, UK
| | - Alan R Smyth
- Academic Unit of Lifespan & Population Health, School of Medicine, University of Nottingham, Nottingham, UK
- NIHR Biomedical Research Centre, Nottingham University Hospital NHS Trust and University of Nottingham, Nottingham, UK
| |
Collapse
|
11
|
Ramondetta LM, Tortolero-Luna G, Bodurka DC, Sills D, Basen-Engquist K, Gano J, Levenback C. Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study. Int J Gynecol Cancer 2004; 14:580-8. [PMID: 15304150 DOI: 10.1111/j.1048-891x.2004.14402.x] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
We sought to explore the Society of Gynecologic Oncologists (SGO) members' opinions and decisions about end-of-life issues and incurable conditions. A survey was mailed to members of the SGO. Their responses were recorded on a Likert scale and entered into a database. The survey explored opinions, experiences, and decisions in managing terminally ill gynecologic oncology patients. Of 900 surveys, 327 were returned (response rate, 36%). Seventy-three percent were men, 89% were white, and 72% were of Christian denomination. Respondents believed that 97% of patients who are dying realize that they are dying but stated only 40% of these patients initiate conversations about end-of-life issues. In contrast, 92% of respondents stated that they initiate end-of-life discussions with patients. Ninety-two percent of respondents thought that the patients should be allowed to make end-of-life choices independently after the facts are given to them. However, 44% thought that it is important to influence the way information is presented, and 54% believe that the gynecologic oncologist (GO) controls the outcome of end-of-life discussions. Although the physicians' sex, race, religion, and age did not correlate with their treatment decisions, religion did correlate with less fear of death (P = 0.011) and less discomfort when talking with patients about death (P = 0.005). Fifty-four percent of respondents believed that the GO controls the outcome of end-of-life discussions, and 40% believe that their actions prolong the process of dying. Expanding our understanding of what motivates GOs to recommend continued treatment over palliation is important for preserving informed patient-motivated end-of-life decisions.
Collapse
Affiliation(s)
- L M Ramondetta
- Department of Gynecologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
| | | | | | | | | | | | | |
Collapse
|
12
|
Ramondetta LM, Tortolero-Luna G, Bodurka DC, Sills D, Basen-Engquist K, Gano J, Levenback C. Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study. Int J Gynecol Cancer 2004. [DOI: 10.1136/ijgc-00009577-200407000-00002] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
We sought to explore the Society of Gynecologic Oncologists (SGO) members' opinions and decisions about end-of-life issues and incurable conditions. A survey was mailed to members of the SGO. Their responses were recorded on a Likert scale and entered into a database. The survey explored opinions, experiences, and decisions in managing terminally ill gynecologic oncology patients. Of 900 surveys, 327 were returned (response rate, 36%). Seventy-three percent were men, 89% were white, and 72% were of Christian denomination. Respondents believed that 97% of patients who are dying realize that they are dying but stated only 40% of these patients initiate conversations about end-of-life issues. In contrast, 92% of respondents stated that they initiate end-of-life discussions with patients. Ninety-two percent of respondents thought that the patients should be allowed to make end-of-life choices independently after the facts are given to them. However, 44% thought that it is important to influence the way information is presented, and 54% believe that the gynecologic oncologist (GO) controls the outcome of end-of-life discussions. Although the physicians' sex, race, religion, and age did not correlate with their treatment decisions, religion did correlate with less fear of death (P = 0.011) and less discomfort when talking with patients about death (P = 0.005). Fifty-four percent of respondents believed that the GO controls the outcome of end-of-life discussions, and 40% believe that their actions prolong the process of dying. Expanding our understanding of what motivates GOs to recommend continued treatment over palliation is important for preserving informed patient-motivated end-of-life decisions.
Collapse
|